StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.58−0.07 (-11.13%)

Close on Nov 16, 2026Market cap $8.93MP/E –Yield –

Dare Bioscience ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Dare Bioscience's ebitda for the twelve months ending Jun 30, 2026 was -$8.98M. For fiscal 2025 it was -$11.92M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.92M–
FY2024Dec 31, 2024-$23.41M–
FY2016Dec 31, 2016-$369.59K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.40M–
Q1 FY2026Mar 31, 2026-$2.44M–
Q4 FY2025Dec 31, 2025-$936.87K–
Q3 FY2025Sep 30, 2025-$3.20M–
Q2 FY2025Jun 30, 2025-$3.37M–
Q1 FY2025Mar 31, 2025-$4.41M–
Q4 FY2024Dec 31, 2024-$5.38M–
Q3 FY2024Sep 30, 2024-$4.67M–
Q2 FY2024Jun 30, 2024-$7.34M–
Q1 FY2024Mar 31, 2024-$6.01M-9790.5%
Q2 FY2017Jun 30, 2017-$465.62K–
Q1 FY2017Mar 31, 2017-$162.46K–
Q4 FY2016Dec 31, 2016-$122.64K–
Q3 FY2016Sep 30, 2016$62.04K–

More Dare Bioscience figures

See a number that looks wrong?